More so looking for private investors. They can't dillute they need the market cap at $50 mill to meet listing requirements. That won't help at this price.
The inevitable funding cuts to healthcare is becoming a worry for all of these biotech companies. You see a lot of them trading at their lows currently. Too much confusion in the white house.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.